novo nordisk oral semaglutide brand name Nordisk's weight-loss pill wins FDA approval Novo Nordisk's Rybelsus officially retired

Only 15% of patients prescribed GLP-1s for weight loss were still taking the medications two years later, according to an analysis of pharmacy claims posted on July 10th by the pharmacy benefit manager, Prime Therapeutics

These reactions can range from mild redness and swelling to more severe pain and inflammation

Instead of visiting a clinic, users complete a digital health intake, get reviewed by a licensed medical provider, and, if approved, receive their medication delivered to their home

Septerna Sector: GPC Septerna R-targeted oral small molecule drug discovery, including GLP-1, GIP, and glucagon receptors HQ: South San Francisco, CA Year Founded: 2019 (under the name GPCR NewCo, Inc.)

Experienced professionals at Wilson Aesthetics will develop a tailored anti-aging and skin health plan for every individual